NRX PharmaceuticalsNRXP
13F holders, Q1 2026 (March 31)33holders +5
9new positions
4sold out
$2.13avg. 13F price*
At the end of Q1 2026, 33 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, up 5 from Q4 2025. 9 opened new positions and 4 sold out. The largest holders were B Group, Inc. ($6.4M), Vanguard Capital Management LLC ($2.5M) and AdvisorShares Investments LLC ($896K).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $6.8M |
| Exits | 4 | $8.3M |
All 13F filers, Q4 2025 → Q1 2026: 3,489,746 shares bought and 3,080,612 shares sold, net +409,134 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| B Group, Inc. | 4.74% | New | 3,000,000 | $6.4M |
| Vanguard Capital Management LLC | 0.00% | — | 1,160,184 | $2.5M |
| AdvisorShares Investments LLC | 0.16% | Add +28.2% | 420,467 | $896K |
| Commonwealth Equity Services, LLC | 0.00% | Add +8.4% | 397,431 | $847K |
| Geode Capital Management, LLC | 0.00% | Add +41.7% | 310,112 | $661K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 169,580 | $361K |
| Bleakley Financial Group, LLC | 0.00% | No change | 117,204 | $250K |
| BlackRock, Inc. | 0.00% | Add +19.8% | 98,995 | $211K |
| State Street Corp. | 0.00% | No change | 86,984 | $185K |
| XTX Topco Ltd | 0.00% | New | 78,733 | $168K |
| Chicago Partners Investment Group LLC | 0.00% | Add +3.2% | 34,479 | $102K |
| Jane Street Group, LLC | 0.00% | Add +16.0% | 44,152 | $94K |
| Northern Trust Corp. | 0.00% | Add +50.2% | 43,469 | $93K |
| One Wealth Management Investment & Advisory Services, LLC | 0.11% | Add +14.3% | 43,309 | $92K |
| Headlands Technologies LLC | 0.01% | New | 39,394 | $84K |
| Axq Capital, LP | 0.01% | New | 33,211 | $71K |
| Virtu Financial LLC | 0.00% | New | 31,785 | $68K |
| UBS Group AG | 0.00% | Add +613.0% | 25,227 | $54K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 19,876 | $42K |
| Ethos Financial Group, LLC | 0.00% | Add +33.6% | 15,900 | $34K |
| Sjbenen Advisory, LLC | 0.03% | No change | 15,000 | $32K |
| Morgan Stanley | 0.00% | Reduce -0.0% | 10,028 | $21K |
| SBI Securities Co., Ltd. | 0.00% | No change | 2,500 | $5K |
| Wells Fargo & Company | 0.00% | Add +17.5% | 2,350 | $5K |
| Royal Bank of Canada | 0.00% | Add +25.4% | 2,509 | $5K |
| Summit Securities Group LLC | 0.00% | New | 1,135 | $2K |
| Group One Trading LLC | 0.00% | New | 737 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 90 | $191 |
| Tower Research Capital LLC (TRC) | 0.00% | Add +8000.0% | 81 | $173 |
| JPMorgan Chase & Co. | 0.00% | No change | 34 | $71 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $47 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1 | $2 |
| Avion Wealth | 0.00% | New | 294 | $0 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.